Company Directory - Merck & Co., Inc.
Company Details - Merck & Co., Inc.
Merck & Co., Inc.
WebsiteKenilworth, United States
ISIN: US58933X1054
Merck & Co., Inc. is a global healthcare company known for its innovative pharmaceutical products and vaccines, including the HPV vaccine Gardasil. The company focuses on research, development, and manufacturing of medicines addressing a wide range of health challenges.
CCI Score
CCI Score: Merck & Co., Inc.
2.89
-0.01%
Latest Event
Senate Investigation Exposes Big Pharma Tax Dodging Practices
A Senate investigation revealed that several major pharmaceutical companies, including Merck & Co., Inc., are implicated in extensive tax dodging schemes that shift domestic profits overseas, thereby undermining public finances and social welfare funding.
Take Action
So what can you do? Support Merck by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
Merck & Co., Inc. is currently rated as an Objector.
Latest Events
- MAR272025
A Senate investigation revealed that several major pharmaceutical companies, including Merck & Co., Inc., are implicated in extensive tax dodging schemes that shift domestic profits overseas, thereby undermining public finances and social welfare funding.
- FEB192025
An OpenSecrets report revealed that Merck & Co spent $9.32 million on lobbying in 2024. This significant expenditure raises concerns over the company's potential to influence public policy and support authoritarian measures through its political contributions.
-40
Political Contributions and Lobbying Efforts
March 22
Merck & Co.'s $9.32 million expenditure on lobbying in 2024 suggests a high level of involvement in shaping public policy. This spending is viewed negatively from an anti-fascist perspective as it may be used to underpin policies favoring corporate interests and potentially authoritarian agendas. The substantial financial resources allocated to political lobbying contribute to the company's complicity in initiatives that could weaken democratic processes.
- OCT282024
Merck & Co. has consistently funneled campaign contributions through its Merck PAC, with a reported over $300,000 disbursement in October leaning toward Republican candidates, including support for the Senate Republican Campaign Committee. This political financial activity raises concerns from an anti‐fascist perspective regarding support for policies that may undermine democratic norms.
-60
Political Contributions and Lobbying Efforts
March 22
The article highlights that Merck & Co. has consistently supported its political action committee (Merck PAC) which, as of October 2024, has disbursed over $300,000 to various political candidates and committees, with a noticeable lean toward Republican recipients. Given the rising concerns about authoritarian tendencies linked to far-right groups and the inherent risk in supporting political entities that may favor policies undermining democratic accountability, this activity is assessed negatively.
Where Big Pharma’s campaign cash is flowing in this election
- APR302024
Merck & Co., Inc. released a comprehensive statement detailing its efforts under the California Transparency in Supply Chains Act. The statement highlights robust measures including supplier due diligence, regular audits, ethical supplier selection, and integrated human rights policies aimed at eradicating modern slavery and human trafficking. These practices underscore the company’s commitment to responsible business practices and the protection of human rights throughout its supply chain.
+80
Supply Chain Ethics
March 22
The statement provides strong evidence of Merck’s commitment to ethical supply chain practices, including detailed processes for supplier selection, due diligence, auditing, and corrective actions against modern slavery and human trafficking. This proactive transparency and accountability foster an ethical business environment that resists exploitative practices and upholds human rights, aligning well with anti-authoritarian and anti-fascist values.
+75
Labor Relations and Human Rights Practices
March 22
Beyond supply chain ethics, the statement emphasizes the integration of human rights into Merck's internal policies, including a robust Code of Conduct, comprehensive training, and whistle-blowing mechanisms. These efforts indicate a strong commitment to protecting labor rights and promoting ethical practices within the organization.
- MAR012024
Merck's 2024 public policy statement outlines its strong commitment to human rights by detailing robust labor rights protections and supply chain due diligence measures. The company emphasizes adherence to international standards, prohibits forced labor, child labor, and discrimination, and holds suppliers accountable to similar standards. This proactive stance is a positive countermeasure against practices that could indirectly support authoritarian regimes.
+85
Labor Relations and Human Rights Practices
March 22
Merck demonstrates a robust commitment to labor rights and human rights practices. The statement details comprehensive measures including the rejection of forced labor and child labor, anti-discrimination policies, and protections for freedom of association. Such initiatives significantly contribute to ethical business practices that resist authoritarian and oppressive structures.
+80
Supply Chain Ethics
March 22
The document emphasizes due diligence in the supply chain by clearly communicating expectations to suppliers and requiring adherence to high human rights standards. This proactive approach helps prevent the use of forced labor and other exploitative practices, thereby reducing the risk of complicity in broader oppressive systems.
- NOV082022
During the 2022 election cycle, Merck contributed at least $67,500 to members of Congress who objected to certifying the 2020 election results. This financial support is seen as bolstering anti-democratic stances that undermine electoral legitimacy and potentially aid authoritarian agendas.
-40
Political Contributions and Lobbying Efforts
October 12
Merck's contribution of $67,500 during the 2022 election cycle to members of Congress who opposed certifying the 2020 presidential election results suggests an alignment with anti-democratic and authoritarian tendencies. Such financial support for political figures challenging the democratic process raises concerns about corporate complicity in undermining electoral legitimacy and enabling authoritarian practices.
- JAN012020
The company outlines its proactive commitment to uphold human rights across its operations, ensuring no violations occur in its own sites or within its supply chain. The published policies emphasize due diligence, alignment with international standards, and prevention of forced labor or exploitation.
+70
Business Practices and Ethical Responsibility
March 22
The company’s detailed human rights policy underscores a commitment to ethical business practices by integrating international standards and statutory obligations into their operations. This proactive stance reflects positively on their overall business practices and ethical responsibility.
+80
Labor Relations and Human Rights Practices
March 22
By explicitly integrating human rights due diligence into its operational and supply chain processes, the company demonstrates a robust commitment to labor relations and human rights practices. This positive initiative helps mitigate risks of exploitation and supports fair treatment of workers.
Alternatives
Corporation
2.31
Indianapolis, United States
-35.34
Basel, Switzerland
-19.75
New Haven, USA
-38.83
Corporation
1.66
Corporation
1.00
Corporation
-12.13
Japan
26.16
Copenhagen, Denmark
2.36
Corporation
3.48
Industries
- 325411
- Medicinal and Botanical Manufacturing
- 325412
- Pharmaceutical Preparation Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology